Several brokerages have updated their recommendations and price targets on shares of MasTec (NYSE: MTZ) in the last few weeks: 10/12/2026 – MasTec had its “overweight” rating reaffirmed by Cantor Fitzgerald. They now have a $348.00 price target on the stock. 10/8/2026 – MasTec had its price target lowered by Stifel Nicolaus from $376.00 to […]

Bank of New York Mellon (NYSE: BNY) recently received a number of ratings updates from brokerages and research firms: 10/8/2026 – Bank of New York Mellon is now covered by TD Cowen. They set a “hold” rating and a $160.00 price target on the stock. 10/5/2026 – Bank of New York Mellon had its price […]

MGM Resorts International (NYSE: MGM) recently received a number of ratings updates from brokerages and research firms: 10/13/2026 – MGM Resorts International was given a new $30.00 price target by The Goldman Sachs Group, Inc.. 10/12/2026 – MGM Resorts International had its price target lowered by Citigroup Inc. from $48.00 to $32.00. They now have […]

Dell Technologies (NYSE: DELL) has recently received a number of price target changes and ratings updates: 10/9/2026 – Dell Technologies had its “buy” rating reaffirmed by The Goldman Sachs Group, Inc.. 10/6/2026 – Dell Technologies had its price target raised by Mizuho from $600.00 to $650.00. They now have an “outperform” rating on the stock. […]

A number of firms have modified their ratings and price targets on shares of Red Rock Resorts (NASDAQ: RRR) recently: 10/12/2026 – Red Rock Resorts had its price target lowered by Citigroup Inc. from $78.00 to $69.00. They now have a “buy” rating on the stock. 10/9/2026 – Red Rock Resorts had its price target […]

Apple (NASDAQ: AAPL) has recently received a number of price target changes and ratings updates: 10/12/2026 – Apple had its price target raised by JPMorgan Chase & Co. from $340.00 to $360.00. They now have an “overweight” rating on the stock. 10/8/2026 – Apple was upgraded by Weiss Ratings from “buy (b-)” to “buy (b)”. […]

Seaport Therapeutics (NASDAQ: SPTX) recently received a number of ratings updates from brokerages and research firms: 10/8/2026 – Seaport Therapeutics had its “buy” rating reaffirmed by UBS Group AG. 10/8/2026 – Seaport Therapeutics had its “buy” rating reaffirmed by HC Wainwright. They now have a $50.00 price target on the stock. 9/25/2026 – Seaport Therapeutics […]

Several brokerages have updated their recommendations and price targets on shares of Monte Rosa Therapeutics (NASDAQ: GLUE) in the last few weeks: 10/5/2026 – Monte Rosa Therapeutics was given a new $25.00 price target by Raymond James Financial, Inc.. 10/5/2026 – Monte Rosa Therapeutics had its “buy” rating reaffirmed by Benchmark Co.. 10/1/2026 – Monte […]

A number of firms have modified their ratings and price targets on shares of Illinois Tool Works (NYSE: ITW) recently: 10/9/2026 – Illinois Tool Works was given a new $277.00 price target by UBS Group AG. 10/9/2026 – Illinois Tool Works was downgraded by JPMorgan Chase & Co. from “overweight” to “neutral”. They now have […]

Beta Bionics (NASDAQ: BBNX) recently received a number of ratings updates from brokerages and research firms: 10/6/2026 – Beta Bionics is now covered by Barclays PLC. They set an “overweight” rating and a $30.00 price target on the stock. 10/6/2026 – Beta Bionics was upgraded by Barclays PLC to “strong-buy”. 9/24/2026 – Beta Bionics had […]

Baker Hughes (NASDAQ: BKR) recently received a number of ratings updates from brokerages and research firms: 9/30/2026 – Baker Hughes had its price target lowered by UBS Group AG from $72.00 to $69.00. They now have a “neutral” rating on the stock. 9/29/2026 – Baker Hughes had its “buy” rating reaffirmed by The Goldman Sachs […]

Plains GP (NYSE: PAGP) has recently received a number of price target changes and ratings updates: 10/6/2026 – Plains GP was upgraded by Zacks Research from “hold” to “strong-buy”. 9/21/2026 – Plains GP had its price target raised by Barclays PLC from $23.00 to $24.00. They now have an “underweight” rating on the stock. 9/21/2026 […]

A number of research firms have changed their ratings and price targets for BCB Bancorp, Inc. (NJ) (NASDAQ: BCBP): 9/21/2026 – BCB Bancorp, Inc. (NJ) had its price target lowered by Piper Sandler from $11.00 to $9.50. They now have a “neutral” rating on the stock. 9/19/2026 – BCB Bancorp, Inc. (NJ) was downgraded by […]

Several analysts have recently updated their ratings and price targets for AnaptysBio (NASDAQ: ANAB): 10/4/2026 – AnaptysBio was downgraded by Wall Street Zen from “buy” to “hold”. 9/30/2026 – AnaptysBio had its price target lowered by JPMorgan Chase & Co. from $70.00 to $60.00. They now have an “overweight” rating on the stock. 9/26/2026 – […]

Several analysts have recently updated their ratings and price targets for Regeneron Pharmaceuticals (NASDAQ: REGN): 10/6/2026 – Regeneron Pharmaceuticals had its price target raised by JPMorgan Chase & Co. from $900.00 to $950.00. They now have an “overweight” rating on the stock. 10/1/2026 – Regeneron Pharmaceuticals had its price target raised by Jefferies Financial Group […]

Several analysts have recently updated their ratings and price targets for Vicor (NASDAQ: VICR): 10/1/2026 – Vicor was upgraded by Zacks Research from “hold” to “strong-buy”. 10/1/2026 – Vicor had its price target raised by Needham & Company LLC from $320.00 to $350.00. They now have a “buy” rating on the stock. 9/22/2026 – Vicor […]

A number of research firms have changed their ratings and price targets for Toll Brothers (NYSE: TOL): 10/6/2026 – Toll Brothers had its price target lowered by Barclays PLC from $122.00 to $118.00. They now have an “underweight” rating on the stock. 10/6/2026 – Toll Brothers is now covered by Melius Research. They set a […]

Several analysts have recently updated their ratings and price targets for Cummins (NYSE: CMI): 10/5/2026 – Cummins had its price target lowered by Truist Financial Corporation from $894.00 to $779.00. They now have a “buy” rating on the stock. 9/30/2026 – Cummins had its price target lowered by UBS Group AG from $835.00 to $741.00. […]

Netflix (NASDAQ: NFLX) has recently received a number of price target changes and ratings updates: 10/5/2026 – Netflix had its “buy” rating reaffirmed by TD Cowen. They now have a $100.00 price target on the stock. 10/1/2026 – Netflix had its “buy” rating reaffirmed by Guggenheim. They now have a $80.00 price target on the […]

Copart (NASDAQ: CPRT) recently received a number of ratings updates from brokerages and research firms: 9/28/2026 – Copart had its “outperform” rating reaffirmed by BNP Paribas Exane. They now have a $43.00 price target on the stock, up from $40.00. 9/16/2026 – Copart was downgraded by HSBC Holdings plc from “buy” to “hold”. They now […]

A number of research firms have changed their ratings and price targets for CenterPoint Energy (NYSE: CNP): 9/18/2026 – CenterPoint Energy had its price target lowered by Morgan Stanley from $39.00 to $38.00. They now have an “equal weight” rating on the stock. 9/15/2026 – CenterPoint Energy is now covered by Royal Bank Of Canada. […]

A number of research firms have changed their ratings and price targets for Macy’s (NYSE: M): 9/20/2026 – Macy’s was upgraded by Wall Street Zen from “hold” to “buy”. 9/17/2026 – Macy’s had its “sell” rating reaffirmed by UBS Group AG. 9/14/2026 – Macy’s had its “hold” rating reaffirmed by TD Cowen. 9/12/2026 – Macy’s […]

A number of firms have modified their ratings and price targets on shares of Hewlett Packard Enterprise (NYSE: HPE) recently: 10/2/2026 – Hewlett Packard Enterprise was upgraded by Daiwa Securities Group Inc. from “neutral” to “outperform”. They now have a $75.00 price target on the stock. 10/1/2026 – Hewlett Packard Enterprise had its price target […]

Several brokerages have updated their recommendations and price targets on shares of First Hawaiian (NASDAQ: FHB) in the last few weeks: 10/1/2026 – First Hawaiian had its price target lowered by Piper Sandler from $30.00 to $27.00. They now have a “neutral” rating on the stock. 10/1/2026 – First Hawaiian was upgraded by JPMorgan Chase […]